hemolytic jaundice	is a	neonatal jaundice
perinatal jaundice	is a	neonatal jaundice
neonatal jaundice	is a	bilirubinopathy
jaundice	is a	symptom
bilirubin	is a	pigment
indirect bilirubin	is a	bilirubin
direct bilirubin	is a	bilirubin
indirect bilirubin	converts to	direct bilirubin
indirect bilirubin	accumulates in	brain
kernicterus	is a	brain injury
hemolysis	causes	indirect bilirubin
Rh incompatibility	causes	neonatal jaundice
ABO incompatibility	causes	neonatal jaundice
prematurity	increases risk of	neonatal jaundice
prematurity	associated with	low birth weight
low birth weight	increases risk of	hyperbilirubinemia
exchange transfusion	used for	bilirubin excess
phototherapy	used for	indirect bilirubin excess
phototherapy	treats	hyperbilirubinemia
exchange transfusion	treats	severe hyperbilirubinemia
neonate	affected by	jaundice
mother	implicated in	ABO incompatibility
mother	implicated in	Rh incompatibility
anti-D immunoglobulin	prevents	Rh incompatibility
incompatibility	leads to	hemolysis
hemolysis	leads to	anemia
anemia	worsens	jaundice
bilirubin metabolism	involves	liver
bilirubin metabolism	involved in	newborn
liver	conjugates	bilirubin
conjugated bilirubin	is a	bilirubin
unconjugated bilirubin	is a	bilirubin
unconjugated bilirubin	increases	in hemolysis
unconjugated bilirubin	crosses	blood-brain barrier
blood-brain barrier	breached by	indirect bilirubin
kernicterus	risk factor	prematurity
kernicterus	risk for	neurodevelopmental impairment
neurodevelopmental impairment	results from	kernicterus
newborn	monitored with	bilirubin levels
bilirubin levels	rise with	hemolysis
hemolysis	associated with	Erythroblastosis fetalis
erythroblastosis fetalis	caused by	Rh incompatibility
erythroblastosis fetalis	treated with	exchange transfusion
bilirubin	measured by	total serum bilirubin
total serum bilirubin	used for	jaundice assessment
jaundice assessment	guides	treatment decision
phototherapy	side effects	temperature change
phototherapy	safety concerns	skin damage
exchange transfusion	risks	infection
exchange transfusion	effects	bilirubin reduction
lactation	reduces	bilirubin excretion
breastfeeding	delays	bilirubin clearance
breast milk jaundice	occurs in	newborns
breastfeeding	associated with	breast milk jaundice
sepsis	worsens	hyperbilirubinemia
bilirubin clearance	decreases with	immaturity
bilirubin clearance	predicts	readmission risk
readmission risk	associated with	jaundice
unresolved jaundice	leads to	kernicterus risk
kernicterus risk	informs	public health policy
indirect bilirubin	levels rise	in hemolysis
direct bilirubin	levels rise	in liver dysfunction
kernicterus	causes	neurodevelopmental delay
newborn	requires	bilirubin monitoring
bilirubin monitoring	guides	treatment escalation
treatment escalation	includes	phototherapy
treatment escalation	includes	exchange transfusion
neonatal jaundice	prevalence	high in prematurity
prematurity	limits	bilirubin conjugation
bilirubin conjugation	efficiency	low in neonates
neonatal jaundice	commonly resolves	spontaneously
spontaneous resolution	occurs after	birth
birth	defines	perinatal period
perinatal period	includes	first week of life
first week of life	labeled as	early neonatal period
early neonatal period	duration	seven days
bilirubin	measured in	plasma
plasma bilirubin	reflects	severity
severity	guides	treatment
treatment	aims	bilirubin reduction
bilirubin reduction	improves	outcomes
outcomes	include	neurodevelopment
neurodevelopment	assessed by	milestones
milestones	monitored	long-term follow-up
long-term follow-up	includes	developmental screening
developmental screening	detects	deficits
deficits	associated with	kernicterus
kernicterus	is a	preventable complication
preventable complication	reduces	healthcare burden
healthcare burden	decreases with	early screening
early screening	implemented by	healthcare system
healthcare system	aims to	reduce readmission
readmission	risk increases with	unresolved jaundice
unresolved jaundice	leads to	kernicterus risk
kernicterus risk	informs	public health policy
